Transgenic overexpression of bone morphogenetic protein 11 propeptide in skeleton enhances bone formation

Biochemical and Biophysical Research Communications

Volumn 416, Issue 3-4, 2011, Pages 289-292

  Li, Zicong ^a,b   Zeng, Fang ^b   Mitchell, Alva D ^c   Kim, Yong Soo ^a   Wu, Zhenfang ^b   Yang, Jinzeng ^a  

^a UNIVERSITY OF HAWAII   (United States)

^b SOUTH CHINA AGRICULTURAL UNIVERSITY   (China)

^c AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

BMP11 propeptide; GDF11; Osteoblast; Skeleton; Transgenic mice

Indexed keywords

ALKALINE PHOSPHATASE; ALPHA1 TYPE 1 COLLAGEN; BONE MORPHOGENETIC PROTEIN 11; COLLAGEN; GROWTH FACTOR; OSTEOCALCIN; PHOSPHATE REGULATING NEUTRAL ENDOPEPTIDASE; PROTEIN PRECURSOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MINERAL; CELL FUNCTION; CERVICAL SPINE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETON; THORACIC SPINE; TRABECULAR BONE; TRANSGENIC MOUSE;

ANIMALS; BIOLOGICAL MARKERS; BONE DENSITY; BONE MORPHOGENETIC PROTEINS; GENE EXPRESSION; GROWTH DIFFERENTIATION FACTORS; MICE; MICE, TRANSGENIC; OSTEOBLASTS; OSTEOGENESIS; TRANSGENES;

CALVATIA; MUS; MUS MUSCULUS;

EID: 84855868347     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.11.019     Document Type: Article

References (21)

1. Canalis E., Economides A.N., Gazzerro E. Bone morphogenetic proteins, their antagonists, and the skeleton. Endocrine Reviews 2003, 24:218-235.
2. Zhao G.Q. Consequences of knocking out bmp signaling in the mouse. Genesis 2003, 35:43-56.
3. Bragdon B., Moseychuk O., Saldanha S., King D., Julian J., Nohe A. Bone morphogenetic proteins: a critical review. Cellular Signalling 2011, 23:609-620.
4. Gamer L.W., Wolfman N.M., Celeste A.J., Hattersley G., Hewick R., Rosen V. A novel bmp expressed in developing mouse limb, spinal cord, and tail bud is a potent mesoderm inducer in xenopus embryos. Developmental Biology 1999, 208:222-232.
5. Nakashima M., Toyono T., Akamine A., Joyner A. Expression of growth/differentiation factor 11, a new member of the bmp/tgf beta superfamily during mouse embryogenesis. Mechanisms of Development 1999, 80:185-189.
6. McPherron A.C., Lawler A.M., Lee S.J. Regulation of anterior/posterior patterning of the axial skeleton by growth/differentiation factor 11. Nature Genetics 1999, 22:260-264.
7. Gamer L.W., Cox K.A., Small C., Rosen V. Gdf11 is a negative regulator of chondrogenesis and myogenesis in the developing chick limb. Developmental Biology 2001, 229:407-420.
8. McPherron A.C., Huynh T.V., Lee S.J. Redundancy of myostatin and growth/differentiation factor 11 function. BMC Developmental Biology 2009, 9:24.
9. Ge G., Hopkins D.R., Ho W.B., Greenspan D.S. Gdf11 forms a bone morphogenetic protein 1-activated latent complex that can modulate nerve growth factor-induced differentiation of pc12 cells. Molecular and Cellular Biology 2005, 25:5846-5858.
10. Li Z., Kawasumi M., Zhao B., Moisyadi S., Yang J. Transgenic over-expression of growth differentiation factor 11 propeptide in skeleton results in transformation of the seventh cervical vertebra into a thoracic vertebra. Molecular Reproduction and Development 2010, 77:990-997.
11. Mitchell A.D., Wall R.J. In vivo evaluation of changes in body composition of transgenic mice expressing the myostatin pro domain using dual energy X-ray absorptiometry. Growth, Development, and Aging 2007, 70:25-37.
12. Li Z., Cao B., Zhao B., Yang X., Fan M.Z., Yang J. Decreased expression of calpain and calpastatin mrna during development is highly correlated with muscle protein accumulation in neonatal pigs. Comparative Biochemistry and Physiology Part A: Molecular and Integrative Physiology 2009, 152:498-503.
13. Ecarot B., Desbarats M. 1, 25-(oh)2d3 down-regulates expression of phex, a marker of the mature osteoblast. Endocrinology 1999, 140:1192-1199.
14. Franz-Odendaal T.A., Hall B.K., Witten P.E. Buried alive: how osteoblasts become osteocytes. Developmental Dynamics 2006, 235:176-190.
15. Hamrick M.W., Shi X., Zhang W., Pennington C., Thakore H., Haque M., Kang B., Isales C.M., Fulzele S., Wenger K.H. Loss of myostatin (gdf8) function increases osteogenic differentiation of bone marrow-derived mesenchymal stem cells but the osteogenic effect is ablated with unloading. Bone 2007, 40:1544-1553.
16. Hamrick M.W., McPherron A.C., Lovejoy C.O. Bone mineral content and density in the humerus of adult myostatin-deficient mice. Calcified Tissue International 2002, 71:63-68.
17. Hamrick M.W., Arounleut P., Kellum E., Cain M., Immel D., Liang L.F. Recombinant myostatin (GDF-8) propeptide enhances the repair and regeneration of both muscle and bone in a model of deep penetrant musculoskeletal injury. Journal of Trauma 2010, 69:579-583.
18. Harrison C.A., Al-Musawi S.L., Walton K.L. Prodomains regulate the synthesis, extracellular localisation and activity of TGF-β superfamily ligands. Growth Factors 2011, 29:174-186.
19. Yang J., Ratovitski T., Brady J.P., Solomon M.B., Wells K.D., Wall R.J. Expression of myostatin pro domain results in muscular transgenic mice. Molecular Reproduction and Development 2001, 60:351-361.
20. Yang J., Zhao B. Postnatal expression of myostatin propeptide cDNA maintained high muscle growth, normal adipose tissue mass in transgenic mice fed a high-fat diet. Molecular Reproduction and Development 2006, 73:462-469.
21. Li Z., Zhao Z.B., Kim Y.S., Hu C.Y., Yang J. Administration of a mutated myostatin propeptide to neonatal mice significantly enhances skeletal muscle growth. Molecular Reproduction and Development 2009, 77:76-82.